Clinical Trial Update: [18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers

View source ↗

Summary

Completed clinical trial evaluating 18F-Flourothymidine (FLT) PET/CT imaging for gynecologic cancers with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Gynecologic Cancer | Status: COMPLETED | Results posted: 2019-11-08